Fairvalue-Calculator Fairvalue-Calculator
EN DE

Bonesupport Holding (BONEX) Fair Value & Analysis

Healthcare · SE · Market cap 14.9B SEK

Pricekr 202.20
Fair Valuekr 59.07
Upside-70.8%
Quality95/100
Evidence: High Range kr 43.02 – kr 120.69

Fair value as of: Jun 24, 2026

Analysis

Bonesupport Holding (BONEX) currently trades at kr 202.20, while our model-based Fair Value estimate is kr 59.07 — implying the stock looks roughly 70.8% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone graft substitute that remodels to host bone and elutes Vancomycin during the critical first 30 days of bone healing, as well as treats and prevents bone infection. It also provides CERAMENT Bead Tray, an adjunctive local delivery option for surgeons desiring targeted delivery to osseous defects and for dead space management. Bonesupport Holding AB (publ) was founded in 1999 and is headquartered in Lund, Sweden.

Open the full interactive analysis →

Similar stocks

Intuitive Surgical, Inc (ISRG) -62% EssilorLuxottica Société anonyme (ESLOF) -34% HOYA Corporation (HOCPY) -38% Medline Inc (MDLN) -15% Becton, Dickinson and Company (BDX) -22% Alcon Inc (ALC) -44%

Frequently asked questions

Is Bonesupport Holding (BONEX) undervalued?
As of Jun 24, 2026, our model estimates a fair value of kr 59.07 versus a price of kr 202.20 — about −71% (overvalued). Model-based estimate, not financial advice.
What is the fair value of BONEX?
Our 21-model fair value for Bonesupport Holding is kr 59.07 (as of Jun 24, 2026), built from audited fundamentals. The current price is kr 202.20.
What is the quality score of BONEX?
Bonesupport Holding has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.